Evidence map›Paper›PMID 40634108›Full record

ArticleRNA (New York, N.Y.)2025

Pseudouridine reprogramming in the human T-cell epitranscriptome: from primary to immortalized states.

Oleksandra Fanari, Dylan Bloch, Yuchen Qiu, Michele Meseonznik, Dinara Boyko, Amr Makhamreh, Meni Wanunu, Sara H Rouhanifard

Abstract read
In one paragraph

Article in RNA (New York, N.Y.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. NanoCortex: A Unified Agentic System for Nanopore Sequencing Analysis.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Oleksandra FanariDepartment of Bioengineering, Northeastern University, Boston, Massachusetts 02120, USA.ORCID 0009-0003-2915-859X
Dylan BlochDepartment of Bioengineering, Northeastern University, Boston, Massachusetts 02120, USA.ORCID 0000-0002-5382-5765
Yuchen QiuDepartment of Bioengineering, Northeastern University, Boston, Massachusetts 02120, USA.ORCID 0009-0001-1544-9682
Michele MeseonznikDepartment of Bioengineering, Northeastern University, Boston, Massachusetts 02120, USA.ORCID 0009-0006-2036-6669
Dinara BoykoDepartment of Bioengineering, Northeastern University, Boston, Massachusetts 02120, USA.
Amr MakhamrehDepartment of Bioengineering, Northeastern University, Boston, Massachusetts 02120, USA.ORCID 0000-0002-4615-5820
Meni WanunuDepartment of Bioengineering, Northeastern University, Boston, Massachusetts 02120, USA.ORCID 0000-0002-9837-0004
Sara H RouhanifardDepartment of Bioengineering, Northeastern University, Boston, Massachusetts 02120, USA s.rouhanifard@northeastern.edu.ORCID 0000-0002-6991-4877

Funding

Synthetic mRNA Control Set for Nanopore-Based Pseudouridine Modification Profiling in Human TranscriptomesR01HG012856 · NHGRI · NORTHEASTERN UNIVERSITY · PI Sara Hakim Rouhanifard · 2023 to 2026
$3.4M
Direct RNA sequencing using electo-optical zero mode waveguides and custom click fluorescent nucleotidesR01HG013304 · NHGRI · NORTHEASTERN UNIVERSITY · PI Meni Wanunu · 2024 to 2026
$3.2M
NHGRI NIH HHS R01 HG012856NHGRI NIH HHS R01 HG013304
6 · The paper itself

Abstract

Immortalized cell lines are commonly used as proxies for primary cells in human biology research. For example, Jurkat leukemic T cells fundamentally contributed to uncovering T-cell signaling, activation, and immune responses. However, the immortalization process can alter key cellular properties, and researchers widely believe this process could significantly change RNA modification machinery and modification sites. In this study, we focus on pseudouridine (ψ), one of the most abundant mRNA modifications, and compare ψ profiles in mRNA from primary and immortalized T cells using direct RNA sequencing (DRS). Surprisingly, 87% of ψ-sites were shared between the two cell types, primarily in transcripts encoding proteins involved in essential cellular processes, including RNA-modification regulation. Furthermore, the analysis of the 13% of sites unique to each cell type reveals that Jurkat cells contained transcripts linked to immune activation and oncogenesis, while primary T cells contained transcripts associated with calcium signaling and intracellular trafficking. We provide a list of these genes, which should be considered when using immortalized cells to study RNA modifications in immunology contexts. Most differences were driven by whether the mRNA was present or absent in the immortalized or primary cell type. Interestingly, RNA-modification enzyme expression levels were highly conserved in both cell types. This suggests that site-specific differences in ψ levels arise from regulatory processes acting in

Indexed as

Cellular ReprogrammingPseudouridineRNA Processing, Post-TranscriptionalT-LymphocytesTranscriptomeHumansJurkat CellsRNA, MessengerPseudouridineRNA, Messengerimmunologynanopore direct RNA sequencingprimary T cellspseudouridineRNA modifications

Identifiers

PMID40634108
PMCPMC12360209

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.